Thus, one of the important aims of the present study was to examine the possible protective effect of Carvedilol, one of the medications for atherosclerosis, on osteoporosis and to evaluate the effects of this drug on MMP-9 activity. This evidence concerns the gene MMP9 and atherosclerosis.